Karl Chalabala Stock Analyst Profile - UBS Research Coverage - Stocknear

Karl Chalabala

Stock Analyst at UBS

(2.96)
# 2981
Out of 5,478 analysts
9
Total ratings
Success rate
Average return
4 Stocks
Name Action PT Current % Upside Ratings Updated
FOLD Amicus Therapeutics
Maintains: Strong Buy
21 22
7.99 175.34% 6 May 2, 2025
SCCO Southern Copper
Maintains: Sell
47 50
106.16 -53.79% 1 Feb 23, 2023
GPOR Gulfport Energy
Maintains: Buy
21 18
174.07 -89.66% 1 Aug 14, 2017
CRK Comstock Resources
Maintains: Buy
14 12
15.96 -24.81% 1 Aug 14, 2017